Written by Brad Shu, Partner, DHH Law Firm Shanghai · All articles are informational only — not legal advice
Market Entry

Buying a Chinese Company: M&A Process, Due Diligence, and Approvals for Foreign Acquirers

How foreign investors acquire Chinese companies — equity vs asset deals, the due diligence that actually finds problems (social insurance, chops, related-party debt), filing mechanics, and closing sequence.

TL;DR — the essentials

  • Most foreign acquisitions of Chinese companies are share transfers in a domestic limited liability company — signed by SPA, completed through SAMR change registration, with negative-list sectors requiring the foreign ownership rules to be satisfied at closing.
  • Asset deals trade tax cost for risk isolation: they avoid inheriting the target's liabilities but trigger transfer taxes (VAT on most assets, land appreciation tax on property, and the 59-orderly-succession rules for employee transfer).
  • Due diligence in China lives or dies on verified public records and off-site interviews — business licences, chop custody, social insurance payment records, litigation and enforcement databases, and related-party balances matter more than the target's own management accounts.
  • No pre-closing antitrust filing for most mid-market deals, but concentration thresholds (combined China turnover above RMB 800 million with two parties each above RMB 400 million) pull acquisitions into SAMR merger control — and gun-jumping fines are per-party and material.
  • Payment and price: the foreign buyer can pay the foreign or domestic seller through the foreign exchange system with proper documentation — but the price must match the declared value, and under-declaring to save transfer taxes is a real enforcement pattern.

The deal shapes

Foreign acquisitions of Chinese companies cluster into three shapes:

  1. Equity transfer — the foreign buyer buys shares from the existing shareholder(s). The company continues; ownership and control change at SAMR registration. This is the workhorse.
  2. Asset acquisition — the foreign buyer (often a new WFOE) buys the business perimeter. The seller keeps the shell and its history.
  3. New equity subscription (capital increase) — the foreign investor subscribes newly issued shares, diluting the founders. Common in growth deals; the money goes into the company, not to sellers.

Negative-list sectors override everything: if the target operates in a restricted sector, the post-closing shareholding must fit the restriction (cap, Chinese control, prohibition), which may require pre-closing divestment of business lines or a JV structure. Outside the list, foreign ownership is unrestricted.

Process timeline: signing to closing

A mid-market equity acquisition (RMB 50–500 million) typically runs:

Phase Weeks Key items
Term sheet / exclusivity 1–2 Lock-in, exclusivity, price range, structure
Due diligence 3–6 Legal, financial, tax, HR, commercial; site visits
Structuring Concurrent Deal entity (HK spv common), negative-list fit, financing
SPA negotiation 2–4 W&Rs, indemnities, conditions, price mechanism
Closing mechanics 2–4 SAMR registration, bank/FX, possession of chops/licences

The distinctive China-closing mechanics: the deal “closes” legally at SAMR change registration (new shareholder registered on the licence), which requires the executed SPA, board/shareholder resolutions, and the new investor’s documents (notarised/apostilled certificate of incorporation — the same lead-time item as a greenfield WFOE). Payment and FX follow the registration, not precede it. And chops and licences change hands at closing — the physical handover of company chops, licence originals, and bank tokens is written into the closing checklist like a horse-and-carriage clause, because possession of chops is practical control.

Due diligence: where Chinese targets actually hide problems

Standard checklists apply, but the findings that move price in China concentrate in a few places:

  • Social insurance under-payment — contributions calculated at the floor or on partial wages. Near-universal in domestic SMEs; the exposure is back-contributions plus late fees for a look-back period, and it is quantifiable (make it a price adjustment or a special indemnity).
  • Chops and control hygiene — who physically holds the chops, the bank tokens, and the licence? Parallel chops (unregistered copies) are a red flag; so is a legal representative who personally holds everything.
  • Related-party balances and flows — shareholder loans, receivables from affiliated companies, personal accounts used for company revenue. The accounts often look fine; the related-party note is where the truth is.
  • Litigation and enforcement searches — the public databases (中国裁判文书网, 执行信息公开网, credit information systems) are the ground truth; a target with “no litigation” per management and three enforcement orders in the databases is telling you something.
  • Tax and invoice history — bought fapiao or mismatched invoices create criminal exposure that travels with the entity in an equity deal. Golden Tax IV data makes discrepancies easier for the bureau to see than for the buyer.
  • IP registrations actually owned by the company — trademarks and patents often sit in the founder’s personal name or an affiliate; the transfer needs its own SPA schedule.
  • Employees and dispatch structures — headcount on paper vs actual, dispatch agency arrangements, unpaid overtime exposure, and key-employee non-competes (enforceable only with compensation paid during the restriction period).
  • Licence and scope fit — does the licence match what the business actually does? Scope mismatches (common after years of drifting business) become the buyer’s problem at closing.

Key deal terms with Chinese characteristics

  • Price mechanisms: price is RMB-denominated and often adjusted to audited net assets or working capital at closing. FX conversion mechanics belong in the SPA — remittance timing is a real risk allocation item.
  • Warranties and indemnities: enforceability against a Chinese individual seller is the weak point — escrow, holdback, or offshore security (if the seller is offshore) are the practical answers. Retention of 10–20% for 12–24 months is standard mid-market.
  • Earn-outs are enforceable but hard to price against a seller who controls the earn-out period’s books — defined accounting standards and audit rights are essential.
  • Non-competes: founder non-competes in the SPA (contractual) differ from employee non-competes (statutory, compensation-dependent). Get both, in the right form.
  • Condition precedents: merger control clearance where thresholds met, negative-list compliance restructuring, key licence confirmations, and material contract consents (change-of-control clauses).

Merger control: the threshold most people guess wrong

SAMR merger control applies to concentrations above turnover thresholds — currently combined China turnover over RMB 800 million and at least two parties each with China turnover over RMB 400 million. Mid-market strategic buyers routinely cross this without realising (the buyer’s China turnover counts too). Filing is pre-closing mandatory; closing without clearance (gun-jumping) draws per-party fines that reached hundreds of millions of RMB in recent penalty decisions. The filing itself takes 1–3 months (simple cases) — build it into the timeline early.

After closing

The paperwork does not end at SAMR: update the FIE information report, re-register tax and customs details, replace bank signatories and FX registration, re-issue social insurance/housing fund registrations, notify major contracts (change-of-control notices), and update the chop registration records. A clean post-closing checklist is what makes the acquired company actually operable by the new owner — and what keeps the seller’s era from resurfacing in year one.

Frequently asked questions

Do I need government approval to buy a Chinese company?
For most sectors, no case-by-case approval — the Foreign Investment Law replaced the old approval regime with information reporting. The acquisition is filed through the FIE information report at SAMR when the change of ownership registers. What still applies: the negative list (if the sector is restricted, the post-closing structure must comply — foreign ownership caps, Chinese-majority requirements — often via a pre-closing restructuring), merger control thresholds at SAMR, and any sector-specific regulator (financial institutions, telecoms, education). ODI filings in the buyer's home jurisdiction are separate and usually the longer lead time.
Equity deal or asset deal — how do I choose?
Equity: the entity and all its history — licences, contracts, employees, and liabilities — transfer intact. Faster, cheaper on transfer taxes, and the only way to keep non-transferable licences. Asset: you buy the business perimeter (assets, contracts by novation, employees by re-hire) and leave the shell with the seller. Slower (each contract needs novation, each licence re-application), heavier on transaction taxes (VAT, deed tax, LAT on property), but quarantines historical liability. The default for most strategic acquisitions is equity with aggressive warranty protection; asset deals win where the target's history is unfixable.
How does payment work if I'm paying from overseas?
The SPA and price flow through the foreign exchange system: if the seller is offshore (a foreign shareholder), payment goes offshore after SAMR registration of the transfer, withholding of transfer income tax and filing of foreigh exchange; if the seller is domestic (a Chinese shareholder), the price is remitted in, certified by the bank against the SPA and tax filings, and paid out to the individual (who owes Chinese IIT on the gain — the buyer must withhold or confirm settlement, and banks check the tax certificate before releasing funds). Declared price and paid price must match; splitting price into an offshore 'service fee' to dodge taxes is a well-known enforcement pattern with clawback risk.

Need help with this? Brad advises clients on exactly this — from WFOE setup to tax structuring and compliance. Tell him about your situation.

Ask Brad

Ask a question about this article

日本語でのご質問も歓迎します。

Your question goes directly to Brad's inbox and is not published — no comment section, no public thread. Please don't include highly confidential details in a first message.

Brad Shu

Partner at DHH Law Firm Shanghai · Formerly Squire Sanders, Morrison Foerster & Jingtian Law Firm · Hangzhou Normal University (B.A. Biology) · Tsinghua University (LL.B.)

Brad Shu is a partner at DHH Law Firm Shanghai and has practiced Chinese law for two decades, including nearly ten years between the Beijing offices of US firms Squire Sanders and Morrison Foerster and leading local firm Jingtian & Gongcheng.